Yu L, Shao Z, Cai S
Cancer Hospital, Shanghai Medical University.
Zhonghua Zhong Liu Za Zhi. 1996 Nov;18(6):429-32.
The relationship between the effect of retinoic acid (RA) on the growth of breast cancer cell and their estrogen receptor (ER) status as well as the relationship between RA effect and the expression of retinoic acid receptorsd (RAR alpha) were studied by cell growth assay, Northern Blot and gene transfection. It was found that RA could only inhibit the growth of ER-positive but not ER-negative breast cancer cells. RAR alpha mRNA level was significantly higher in ER-positive breast cancer cell lines than that in ER-negative breast cancer cell line. The expressions of other subtypes of RAR in ER-positive cells were not significantly different from those in ER-negative ones. When, RAR alpha cDNA was introduced and ixpressed in RA-resistant, ER-negative MDA-MB-231 breast cancer cell line, its growth was strongly inhibited by RA. These results indicate that RAR alpha plays a major role in the retinoi-dmediated inhibition of growth in human breast cancer cells.
通过细胞生长试验、Northern印迹法和基因转染,研究了维甲酸(RA)对乳腺癌细胞生长的影响与其雌激素受体(ER)状态之间的关系,以及RA作用与维甲酸受体d(RARα)表达之间的关系。发现RA仅能抑制ER阳性而非ER阴性乳腺癌细胞的生长。ER阳性乳腺癌细胞系中RARα mRNA水平显著高于ER阴性乳腺癌细胞系。ER阳性细胞中RAR其他亚型的表达与ER阴性细胞中的表达无显著差异。当RARα cDNA导入并在RA耐药的ER阴性MDA-MB-231乳腺癌细胞系中表达时,其生长受到RA的强烈抑制。这些结果表明,RARα在维甲酸介导的人乳腺癌细胞生长抑制中起主要作用。